Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 14, 2018
Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4
Guillaume B E Stewart-Jones, Gwo-Yu Chuang, Kai Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 2020
Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
Mangaiarkarasi Asokan, Joana Dias, Cuiping Liu, et al.
Nature Microbiology
|
April 10, 2025
A broadly protective human antibody for GI genogroup noroviruses
Inga Rimkute, Adam S Olia, Mehin Suleiman, et al.
Science (New York, N.Y.)
|
November 2, 2013
Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus
Jason S McLellan, Man Chen, M Gordon Joyce, et al.
Science Translational Medicine
|
May 6, 2011
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys
Norman L Letvin, Srinivas S Rao, David C Montefiori, et al.
Nature Communications
|
June 22, 2023
Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections
Wanwisa Promsote, Ling Xu, Jason Hataye, et al.
Cell Reports
|
February 15, 2018
Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody
Young D Kwon, Gwo-Yu Chuang, Baoshan Zhang, et al.
Science Translational Medicine
|
June 12, 2020
Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality
Sonia Maciejewski, Tracy J Ruckwardt, Kaitlyn M Morabito, et al.
Iscience
|
February 6, 2024
Long trimer-immunization interval and appropriate adjuvant reduce immune responses to the soluble HIV-1-envelope trimer base
Hongying Duan, Angela R Corrigan, Cheng Cheng, et al.
Science (New York, N.Y.)
|
October 7, 2016
Rapid development of a DNA vaccine for Zika virus
Kimberly A Dowd, Sung-Youl Ko, Kaitlyn M Morabito, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Proceedings of the National Academy of Sciences of the United States of America
|
November 14, 2018
Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4
Guillaume B E Stewart-Jones, Gwo-Yu Chuang, Kai Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 2020
Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
Mangaiarkarasi Asokan, Joana Dias, Cuiping Liu, et al.
Nature Microbiology
|
April 10, 2025
A broadly protective human antibody for GI genogroup noroviruses
Inga Rimkute, Adam S Olia, Mehin Suleiman, et al.
Science (New York, N.Y.)
|
November 2, 2013
Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus
Jason S McLellan, Man Chen, M Gordon Joyce, et al.
Science Translational Medicine
|
May 6, 2011
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys
Norman L Letvin, Srinivas S Rao, David C Montefiori, et al.
Nature Communications
|
June 22, 2023
Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections
Wanwisa Promsote, Ling Xu, Jason Hataye, et al.
Cell Reports
|
February 15, 2018
Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody
Young D Kwon, Gwo-Yu Chuang, Baoshan Zhang, et al.
Science Translational Medicine
|
June 12, 2020
Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality
Sonia Maciejewski, Tracy J Ruckwardt, Kaitlyn M Morabito, et al.
Iscience
|
February 6, 2024
Long trimer-immunization interval and appropriate adjuvant reduce immune responses to the soluble HIV-1-envelope trimer base
Hongying Duan, Angela R Corrigan, Cheng Cheng, et al.
Science (New York, N.Y.)
|
October 7, 2016
Rapid development of a DNA vaccine for Zika virus
Kimberly A Dowd, Sung-Youl Ko, Kaitlyn M Morabito, et al.
Page
of 6